Immuno-oncology (IO) drug conjugate concentrates at cells and tumors and enhances survival

被引:0
|
作者
Kaulagari, Sridhar Reddy [1 ,4 ]
Doligalski, Michael [2 ,3 ]
Cohen, Allison [3 ]
Zheng, Hong [5 ]
Estrella, Veronica [3 ]
Beg, Amer [5 ]
Morse, David [3 ]
McLaughlin, Mark [1 ,4 ]
机构
[1] West Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA
[2] Univ S Florida, Dept Chem, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL USA
[4] Modulat Therapeut Inc, Morgantown, WV USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
109
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative
    Thierry de Baère
    Lambros Tselikas
    Frederic Deschamps
    Jean Charles Soria
    Aurélien Marabelle
    CardioVascular and Interventional Radiology, 2018, 41 : 825 - 827
  • [2] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative
    de Baere, Thierry
    Tselikas, Lambros
    Deschamps, Frederic
    Soria, Jean Charles
    Marabelle, Aurelien
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) : 825 - 827
  • [3] Quantitative modeling as a systematic approach for drug combination evaluation in immuno-oncology (IO)
    Helmlinger, Gabriel
    Kosinsky, Yuri
    Chu, Lulu
    Peskov, Kirill
    Voronova, Veronika
    Borodovsky, Alexandra
    Woessner, Richard
    Sachsenmeier, Kris
    Al-huniti, Nidal
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Immuno-oncology of head and neck tumors
    Kasper, Stefan
    Hussain, Timon
    Virchow, Isabel
    Stuschke, Martin
    Lang, Stephan
    HNO, 2019, 67 (03) : 221 - 235
  • [5] Immuno-oncology of head and neck tumors
    Kasper S.
    Hussain T.
    Virchow I.
    Stuschke M.
    Lang S.
    best practice onkologie, 2018, 13 (6) : 336 - 349
  • [6] Estimating the social value of immuno-oncology (IO) therapies in Japan
    Ohno, T.
    Flottemesch, T. J.
    Aguiar-Ibanez, R.
    Srviastava, K.
    Chou, J.
    Liu, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S945 - S945
  • [7] USE OF GENERALISED FLUCTUATION TEST TO OPTIMISE PIECEWISE FITTING IN IMMUNO-ONCOLOGY (IO) SURVIVAL MODELLING
    Jootun, M.
    Agirrezabal, I
    VALUE IN HEALTH, 2019, 22 : S817 - S817
  • [8] IO plus IO = More to Know: The Uncertain Potential for Combined Interventional and Immuno-Oncology
    Brown, Daniel B.
    Agarwal, Rajiv
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (02) : 196 - 197
  • [9] Immunodynamics of explanted human tumors for immuno-oncology
    Dubuisson, Agathe
    Fahrner, Jean-Eudes
    Goubet, Anne-Gaelle
    Terrisse, Safae
    Voisin, Nicolas
    Bayard, Charles
    Lofek, Sebastien
    Drubay, Damien
    Bredel, Delphine
    Mouraud, Severine
    Susini, Sandrine
    Cogdill, Alexandria
    Rebuffet, Lucas
    Ballot, Elise
    Jacquelot, Nicolas
    Thomas de Montpreville, Vincent
    Casiraghi, Odile
    Radulescu, Camelia
    Ferlicot, Sophie
    Figueroa, David J.
    Yadavilli, Sapna
    Waight, Jeremy D.
    Ballas, Marc
    Hoos, Axel
    Condamine, Thomas
    Parier, Bastien
    Gaudillat, Christophe
    Routy, Bertrand
    Ghiringhelli, Francois
    Derosa, Lisa
    Breuskin, Ingrid
    Rouanne, Mathieu
    Andre, Fabrice
    Lebacle, Cedric
    Baumert, Herve
    Wislez, Marie
    Fadel, Elie
    Cremer, Isabelle
    Albiges, Laurence
    Geoerger, Birgit
    Scoazec, Jean-Yves
    Loriot, Yohann
    Kroemer, Guido
    Marabelle, Aurelien
    Bonvalet, Melodie
    Zitvogel, Laurence
    EMBO MOLECULAR MEDICINE, 2021, 13 (01)
  • [10] Immuno-oncology drug development goes global
    Yu, Jia Xin
    Hubbard-Lucey, Vanessa M.
    Tang, Jun
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (12) : 899 - 900